SCHEMBL5586641

SCHEMBL5586641

CCCCc1c(O)c(OC(=O)O)c(Cl)c(CCCC)c1CCCC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.36
AKR1C2 P52895 1/20 0.33
AKR1C1 Q04828 1/20 0.33
ESR1 P03372 1/20 0.32
TYMP P19971 1/20 0.32
HPGD P15428 3/20 0.32
NPC1 O15118 1/20 0.32
MAPK1 P28482 1/20 0.32
HTT P42858 1/20 0.32
RAB9A P51151 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
PAK1 Q13153 1/20 0.31
ALOX5 P09917 4/20 0.31
KDM4E B2RXH2 2/20 0.30
PKM P14618 1/20 0.30
ALDH1A1 P00352 2/20 0.30
HSD17B10 Q99714 2/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5589096 0.95 ALOX5 (0.35) FFAR1ESR1TYMPHPGDMEN1
SCHEMBL5586786 0.94 ALOX5 (0.38) TYMPALOX5ALDH1A1
SCHEMBL5587381 0.94 ALOX5 (0.38) TYMPALOX5ALDH1A1
SCHEMBL5588846 0.94 ALOX5 (0.38) TYMPALOX5ALDH1A1
SCHEMBL5589721 0.94 ALOX5 (0.38) TYMPALOX5ALDH1A1
SCHEMBL5589639 0.94 FFAR1 (0.36) FFAR1AKR1C2AKR1C1ESR1TYMP
SCHEMBL5589209 0.90 PPARG (0.33)
SCHEMBL5588592 0.89 ALOX5 (0.35) FFAR1ESR1TYMPHPGDMEN1
SCHEMBL5587634 0.88 ALOX5 (0.38) TYMPALOX5ALDH1A1
SCHEMBL5589401 0.88 ALOX5 (0.38) TYMPALOX5ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 FFAR1 2521/4885AKR1C2 2588/4885AKR1C1 2546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.